These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30860067)

  • 1. Mass migration to Europe: an opportunity for elimination of hepatitis B virus?
    Thijssen M; Lemey P; Amini-Bavil-Olyaee S; Dellicour S; Alavian SM; Tacke F; Verslype C; Nevens F; Pourkarim MR
    Lancet Gastroenterol Hepatol; 2019 Apr; 4(4):315-323. PubMed ID: 30860067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B screening and prevalence among resettled refugees - United States, 2006-2011.
    Scott KC; Taylor EM; Mamo B; Herr ND; Cronkright PJ; Yun K; Altshuler M; Shetty S;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(21):570-3. PubMed ID: 26042647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy.
    El-Hamad I; Pezzoli MC; Chiari E; Scarcella C; Vassallo F; Puoti M; Ciccaglione A; Ciccozzi M; Scalzini A; Castelli F;
    J Travel Med; 2015; 22(2):78-86. PubMed ID: 25424439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and clinical outcomes of hepatitis B virus infection among refugees seen at a U.S. travel medicine clinic: 2005-2008.
    Museru O; Franco-Paredes C
    Travel Med Infect Dis; 2009 May; 7(3):171-4. PubMed ID: 19411045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review.
    Seedat F; Hargreaves S; Nellums LB; Ouyang J; Brown M; Friedland JS
    Lancet Infect Dis; 2018 Sep; 18(9):e259-e271. PubMed ID: 29778396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany].
    Hampel A; Solbach P; Cornberg M; Schmidt RE; Behrens GM; Jablonka A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 May; 59(5):578-83. PubMed ID: 27090247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review.
    Myran DT; Morton R; Biggs BA; Veldhuijzen I; Castelli F; Tran A; Staub LP; Agbata E; Rahman P; Pareek M; Noori T; Pottie K
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Hepatitis B Virus Screening, Vaccination, and Linkage to Care Among Newly Arrived Refugees in Four States, 2009-2011.
    Mitruka K; Pezzi C; Baack B; Burke H; Cochran J; Matheson J; Urban K; Ramos M; Byrd K
    J Immigr Minor Health; 2019 Feb; 21(1):39-46. PubMed ID: 29417356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?
    Jazwa A; Coleman MS; Gazmararian J; Wingate LT; Maskery B; Mitchell T; Weinberg M
    Vaccine; 2015 Mar; 33(11):1393-9. PubMed ID: 25595868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus infection among pregnant women in northeastern Romania.
    Woodruff BA; Popovici F; Beldescu N; Shapiro CN; Hersh BS
    Int J Epidemiol; 1993 Oct; 22(5):923-6. PubMed ID: 8282474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
    Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV; da Silva MA; Calçada Cde O; Cavalcante SR; Souto FJ
    Vaccine; 2011 Jul; 29(32):5290-3. PubMed ID: 21605613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global control of hepatitis B virus infection.
    Kao JH; Chen DS
    Lancet Infect Dis; 2002 Jul; 2(7):395-403. PubMed ID: 12127351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B discrimination in everyday life by rural migrant workers in Beijing.
    Leng A; Li Y; Wangen KR; Nicholas S; Maitland E; Wang J
    Hum Vaccin Immunother; 2016 May; 12(5):1164-71. PubMed ID: 27043963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undocumented migrant women in Denmark have inadequate access to pregnancy screening and have a higher prevalence Hepatitis B virus infection compared to documented migrants in Denmark: a prevalence study.
    Wendland A; Ehmsen BK; Lenskjold V; Astrup BS; Mohr M; Williams CJ; Cowan SA
    BMC Public Health; 2016 May; 16():426. PubMed ID: 27216405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low hepatitis B testing among migrants: a cross-sectional study in a UK city.
    Evlampidou I; Hickman M; Irish C; Young N; Oliver I; Gillett S; Cochrane A
    Br J Gen Pract; 2016 Jun; 66(647):e382-91. PubMed ID: 27025556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan.
    Chen CL; Yang JY; Lin SF; Sun CA; Bai CH; You SL; Chen CJ; Kao JH; Chen PJ; Chen DS
    J Hepatol; 2015 Aug; 63(2):354-63. PubMed ID: 25795588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.
    Diarra B; Yonli AT; Ouattara AK; Zohoncon TM; Traore L; Nadembega C; Obiri-Yeboah D; Yara J; Pietra V; Ouedraogo P; Bougouma A; Sanogo R; Simpore J
    Virol J; 2018 Aug; 15(1):121. PubMed ID: 30081915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of HBV screening and vaccination in a migrant population in southern Italy.
    Mazzitelli M; Greco G; Serapide F; Scaglione V; Morrone H; Marascio N; Giancotti A; Liberto M; Matera G; Trecarichi E; Torti C
    Infez Med; 2021 Jun; 29(2):236-241. PubMed ID: 34061789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.